Kodamaea ( Pichia ) ohmeri is a yeast species that has not been reported to be a frequent cause of human infections. The current report describes a case of fungemia caused by K. ohmeri in a 3-year-old female patient hospitalized in the public hospital Maria Alice Fernandes, Natal, RN, Brazil. The patient had previously received antimicrobial therapy due to a peritoneal infection and nosocomial pneumonia, and had a central venous catheter implanted. Kodamaea ohmeri was isolated from blood and the tip of the catheter, 48 h after its implantation. The yeast was identifi ed by standard microbiological methods and sequence analysis of the D1/D2 domains and the ITS 1 ϩ 2 spacer regions of the ribosomal DNA. On CHROMagar Candida medium, the isolate showed a color change from pink to blue. The yeast was susceptible to amphotericin B, and liposomal AmB was used successfully to clear the infection.
Introduction
The incidence of fungal infections caused by a number of unusual fungi has been increasing among hospitalized patients during the last decades [ 1 ] . The use of broad spectrum antibiotics, catheters, transplantation, the occurrence of neutropenia, and depressed cellular immunity are factors usually associated with nosocomial fungemia [ 2 ] . Kodamaea ohmeri is an ascomycetous yeast, formerly classifi ed in Pichia . The genus Kodamaea was separated from the genus Pichia because of a considerable genetic distance as measured by nucleotide sequence analyses of partial sequences of the 18S and 26S ribosomal RNA [ 3 ] , and the monophyly of the genus was subsequently supported, e.g., in studies by Lachance et al . and Rosa et al . [ 4, 5 ] . The genus was treated with rocefi n, metronidazole and mebendazole, and underwent colostomy. Clinical examination showed a pale patient in a severe state, internal globular abdomen, hematocrit 27%, leukocytes 5,100 per mm 3 , K 3.9 mg/dl, and Na 118 mg/dl. Two days after admission, she underwent a chest X-ray, which highlighted areas of atelectasis in both lungs. The patient was intubated due to discomfort to the lungs, received concentrated hemacia and was submitted for surgery of the abdomen. Gentamicin, vancomycin and imipenem were used as empirical antimicrobial therapy. On 19 June, the child was subjected to an exploratory laparotomy, characterized by an intestinal perforation caused by Ascaris spp. and an episode of purulent peritonitis. Eleven days after intubation, the child received a central venous catheter (CVC) to receive parenteral nutrition and drug administration. Forty-eight hours after implantation of the catheter, the patient developed an acute fever reaching a temperature of 38.2°C, which led to the removal of the catheter. The child received liposomal amphotericin B, because yeasts were isolated from blood samples and from the tip of the catheter. Fifty-six days after admission, the patient was discharged.
The samples from blood and the tip of catheter were sent to the microbiology laboratory of HMAF for identifi cation and the presence of yeast colonies was revealed after subculturing on Sabouraud dextrose agar (Oxoid, Basingstoke, Hampshire, UK). The yeasts were identifi ed using the ATB ID 32C (BioMérieux, Marcy l´Etoile, France) automated identifi cation tool, and subsequently the identifi cations were confi rmed by the laboratory of mycology of Federal University of Rio Grande do North, using morphological methods (i.e., germ tubes in bovine serum and chlamydospores on corn meal agar), cultivation on CHROMagar plates, and physiological tests. The yeast isolates were identifi ed as Kodamaea ohmeri . No ascospores were seen after 15 days incubation on malt extract-2.5% glucose agar, thus confi rming that the yeast isolates may be heterothallic, which is the most common form in which the species occurs. On CHROMagar medium, the colonies changed from pink to blue after 48 h and ID 32C identifi ed the yeasts as K. ohmeri with 99% probability.
Genomic DNA for molecular studies was isolated as previously described [ 26 ] . Molecular identifi cation of the isolate used sequence analysis of the D1/D2 domains and the ITS 1 ϩ 2 spacer regions of the ribosomal DNA [ 27 ] . Basic Local Alignment Search Tool (BLASTn) [ 28 ] analysis of the ITS (FJ215865) and the D1/D2 (FJ215866) sequences in the NCBI database confi rmed the identity of the yeast as K. ohmeri.
Susceptibility testing was conducted using the standard broth microdilution method as described in the CLSI M27-A2 document [ 29 ] . The concentrations of amphotericin B (Bristol-Myers Squibb, Woerden, The Netherlands), itraconazole (Janssen Research Foundation, Beerse, Belgium), voriconazole (Pfi zer Central Research, Sandwich, United Kingdom) and posaconazole (Schering-Plough, Utrecht, The Netherlands) ranged from 0.016 to 16 mg/l, fl uconazole (Pfi zer Central Research) from 0.063 to 64 mg/l, anidulafungin (Pfi zer Central Research) and caspofungin (Merck Sharp & Dohme BV, Haarlem, The Netherlands) from 0.008 to 8 mg/l and isavuconazole (Basilea Pharmaceutica, Basel, Switzerland) from 0.004 to 4 mg/l. Candida parapsilosis ATCC 22019 and C. krusei ATCC 6258 strains were included as quality controls. The MICs for the quality control strains were all within the reference ranges (data not shown). MIC endpoints of K. ohmeri were determined after 48 h incubation at 35°C both visually and spectrophotometrically at 450 nm (Anthos HT3, Salzburg, Austria) using the Mikrowin 2000 program. The MIC of amphotericin B was assessed as the well with the lowest concentration showing 100% inhibition of growth, while that of fl uconazole, itraconazole, voriconazole, posaconazole, isavuconazole, caspofungin and anidulafungin were read as the well with a prominent decrease in turbidity (approximately Ն 50% growth inhibition) relative to the turbidity in the growth control well. MICs of the K. ohmeri isolate were 0.5 μg/ml for amphotericin B, 8 μg/ml for fl uconazole, 0.125 μg/ml for itraconazole and voriconazole, 0.063 μg/ml for posaconazole, isavuconazole and anidulafungin and 2 μg/ml for caspofungin. No differences were noted between visual and spectrophotometric readings.
Discussion
The spectrum of infections caused by yeasts has undergone signifi cant changes, and less common pathogenic yeasts have been reported as cause of nosocomial infections [ 2, 30 ] . The use of broad spectrum antibiotics, CVCs, transplantation, and the occurrence of neutropenia and depressed cellular immunity are risk factors associated with nosocomial fungemia.
Here, we report a case of infection caused by K. ohmeri in a Brazilian three-year-old girl. Our case represents the second K. ohmeri related infection in Brazil. Kodamaea ohmeri is an ascomycetous yeast that usually occurs in the haploid state. The species occurs as an environmental yeast that has been isolated from various food-related habitats and seawater [ 22 -24 ] . According to the medical literature, the fi rst case of a K. ohmeri -related infection occurred in a 48-year-old, diabetic, insulin-dependent female patient with serious risk factors for immunosuppression [ 8 ] . So far, and including our case, 17 cases of K. ohmeri infection have been reported ( Table 1 ) . The other K. ohmeri-related infection in Brazil was related to a patient with chronic myelogenous leukemia [ 20 ] .
In our case, liposomal amphotericin B cured the infection. This formulation has been used previously for the treatment of a K. ohmeri infection in a pediatric patient [ 17 ] . Interpretative 
